Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp
Status:
Withdrawn
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to prove the safety and efficacy of Levulan Kerastick
(aminolevulinic acid HCl) for Topical Solution 20% followed by 10 J/cm2 of blue light
delivered at 10 mW/cm2 or 20 mW/cm2 in the treatment of multiple actinic keratosis on the
face or balding scalp (the Treatment Area), utilizing a 14-18 hour incubation period.